Trading Summary - October 27. Another satisfactory

New Post Public Reply Private Reply Replies (0) Message Board
AJH92
207
Trading Summary - October 27.

Another satisfactory status quo day for $DIGX as the countdown to the pre-Q3 loading run continues.

After the basher / manipulator debacle yesterday when one of the whales took 10M of their hold back / intimidation stack of 24M at .0004 and the remainder were cancelled, they didn't even bid whack the .0004s to fill the remaining bid from the 2M .0004 ask slap made just before the close yesterday.

Apart from a small 80K buy at .0005, there were no other trades today as nobody is being duped to sell so close to the Q3. Also the whales and many of my followers were concentrating on loading bottom range prices on 5 other alerted stocks of which 3 are likely to run by mid-next week. Thereafter, multiple $5-figure sums will be available to add $DIGX at any price that makes sense for the Q3 and Q4 runs.

As has been evident for several weeks now, nobody is going to get any significant amount of .0003s before the next run.

Nobody is being duped by the previously posted non-credible basher nonsense or by the occasional small paint downs at .0003 or .0004.

The real ask from MMs other than NITE at .0005 was the same at around 13M. It remains to be see how much of the NITE figure is fake and will be pulled when hit hard. 50M has been bought out before and can be again if necessary.

Only 12 trading days remain now to the filing of the Q3 Report (due November 15) - with demand-led pre-runs usually happening beforehand.

Stay sharp if you don't already have all the shares you need to make your profit expectations. Prior warning and / or scanner alerts will not be given on iHub.

Watch closely from now on - continuously if you can - to see if a few of the at least 4 whales known to be in $DIGX decide to take out the .0005s as one did with the .0004s yesterday.

Those that fail to cancel any sell orders at .0005 can expect to lose their shares within seconds / minutes at some point in the coming days / weeks - with probably the same people buying as prior to Q1 & Q2. Timing is likely to depend on whether other picks common to the main buyers are running or not on any particular day - as several are in the frame over the next 1 to 8 weeks with PRs and filings starting to roll out. At least 3 of these have updates due within the next 2 trading days.

Content below the line mainly unchanged from last update - relevant to those that are new here.

There are at least 4 x whales who trade $DIGX continuously throughout each year who will be happy to take around 20M each if anyone is stupid or impatient enough to sell for a loss at any level below the current one. Any shares bought at .0004 will be worth an easy 150%+ profit on any of numerous runs likely to happen through to Q3 and Q4. Shares bought at .0005 should easily return 100%+ at some point.

In my experience, 70M>100M is the optimum amount to take best advantage of each run whilst keeping the 25M cheapest batches for the bigger runs next year (especially Q4 in March 2018 when the full year profits will be up). My cheapest 25M retained for next year will not require any shares bought above .0004 now so all others will be tradeable for up to 100% during the remaining runs in 2017.

Expect the status quo to be maintained until the next pre-Q3 run, with it making little difference to long-term traders whether shares are picked up at .0004/5/6 - they will see a profit on all of them by Q3 / Q4 and on various runs between. the big boys in DIGX will probably be aiming to have an inventory of 50M>120M (based on near instantaneous loading seen across 2 price points in seconds when coming off the inter-Q bottom before).

Also expect an element of the .0003 bidders - particularly those unlikely to fill on paint downs in the time remaining before the next run prior to Q3 at latest - to continue to buy .0004s and .0005s whilst they are still available. Only 30% of the bid at .0003 hitting the ask at .0005 would be sufficient to take out even the current fake ask if left there.

We can now look forward to additional updates on both the possible merger discussed recently and the implementation of the additional services being offered in the chiropractic chain offices - per the Strategic Growth Plan just announced - over the coming days, weeks and months..

The long whales will continue to buy at all prices that makes sense to them at any given point to have a cache for trading on any demand led run, the Q3 and through to the Annual Report in March 2018.

$DIGX will most likely not be allowed to go to previous year-end or inter-Q lows.

In my opinion, nobody has bought $DIGX in 2017 at a price that it isn't likely to exceed in the coming months (2017 high .0013) through to the Annual Report (March 2018).

Ludicrous claims by the notorious bashers currently on iHub - "RFB", "munimi", "Crown Capital" and "surfkast" - are clearly seen as such by all serious traders and now even by most short term (next Q) iHubbers.

Debunking nonsense posted by morons on iHub, there is absolutely no need or intention to do a reverse split. The share structure is exceptionally thin - with no dilution - and the company has been buying back shares. OTC market specialists who trade $DIGX continuously would not be loading 50M>100M shares at these inter-Q bottom prices to trade over the next 6 months if there was even the remote possibility of a reverse split.

Regardless of whether iHub posters lose interest over the coming days and weeks, detailed coverage will continue here as $DIGX remains one of my top picks for repeat profits for those that are patient and trade it to best effect (keep all cheapest batches of shares - create an inventory of shares at higher prices to trade on every run - big or small).

In addition, money is not considered "dead" by the most successful traders in the OTC market when they know it will provide a significant return further down the line because they are in a position to understand and influence - through keen observation and record keeping - what volume of shares is likely to be made available for purchase at any particular level.











American EcoFuels Inc (AEFI) Stock Research Links

AEFI Board Company Profile Buy Rating Time & Sales News Filings Financials
"Per Ardua Ad Astra" - "Through Adversity To The Stars"

A very apposite motto for those who trade successfully in the OTC market..

All posts are my opinion - trade at your own risk.
Scroll down for more posts ▼

Top 10 Most Recent News Articles

YONDELIS: Thai Approval Opens New Sarcoma Treatment Path

Updated Category News Views 27

New Hope for Thai Sarcoma Patients Alright, we’ve got some good news coming out of Thailand, folks. The Thai FDA just greenlit YONDELIS® (trabectedin) for those grappling with advanced soft tissue sarcoma (STS). Now, this isn’t your everyday drug release—it’s a clinical chess move packing potential for patients who’ve run out of other options. December 1st,...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 182

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 105

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
IDEAYA's IDE101: A New Front in Cancer Battle

Updated Category News Views 110

IDEAYA's Bold Move in Precision Medicine IDEAYA Biosciences, no stranger to the frontlines of cancer treatment, is gunning for a breakthrough with their latest pick, IDE101. They're jumping into the ring with a potential first-in-class inhibitor targeting CDKN2A-deficiency—a notorious player in the solid tumor game. They're not just mixing things up for the sake of it;...

Continue Reading
Uber Data Breach: Class Action Investigation Begins

Updated Category News Views 247

When Tech Meets Trouble: Uber's Data Breach Picture this: the hum of Uber rides weaving through your city, drivers none the wiser that personal info has been pried from the vaults thanks to their tech partner, Fireworks AI. Uber, folks, is in hot water once again. This isn’t just another tech hiccup; it's a legal whirlwind brewing up courtesy of Edelson Lechtzin LLP, a...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 116

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 351

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 0

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 220

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Investors Gear Up for Lennar Class Action Lawsuit

Updated Category News Views 197

High Stakes and Hard Hits for Lennar Stockholders There’s rarely a dull moment in the world of Wall Street, and Lennar Corporation (NYSE: LEN) is proving that rule right now. As a whiff of scandal wafts through the air, the famed homebuilder and its bigwigs are staring down the barrel of a formidable class action lawsuit. The question is, just how deep do the alleged...

Continue Reading

Top 5 Most Recently Viewed Articles

NexPoint Real Estate Finance, Inc. Updates on Preferred Stock Dividend

Updated Category News Views 252

NexPoint Real Estate Finance, Inc. Updates on Preferred Stock Dividend NexPoint Real Estate Finance, Inc. (NYSE: NREF) has announced an important update regarding its Series A Cumulative Redeemable Preferred Stock. The company is set to distribute a dividend of $0.53125 per share to its loyal stockholders. This announcement signifies a continued commitment to enhancing...

Continue Reading
Strategic Insights from the Recent Bond Offering Results

Updated Category News Views 284

Overview of Recent Bond Offerings Lánasjóður sveitarfélaga recently conducted a series of bond offerings, showcasing their commitment to financing community projects. This initiative occurred under the categories LSS 39 0303 and LSS 151155, with significant investor interest and competitive rates. Details of Bond Offers The offering for LSS 39 0303 attracted bids...

Continue Reading
How Economic Factors Impact Oil Prices and Consumer Confidence

Updated Category News Views 218

Oil prices took a serious nosedive, with Brent crude futures down 1.59% and U.S. West Texas Intermediate following suit. Traders were glued to their screens as the numbers came in, all pointing back to a disappointing inflation report from China that left many scratching their heads about the country's economic health and its appetite for oil. China's Inflation Blues: A...

Continue Reading
Beyond Oil Expands Its Global Footprint with New Deal in Greece

Updated Category News Views 379

Beyond Oil Enters the Greek Market Through a New Partnership Beyond Oil Ltd. (CSE: BOIL) (OTCQB: BEOLF) (Frankfurt: UH9), a pioneering food-tech company dedicated to minimizing health risks linked to fried foods while optimizing operational costs and sustainability practices, is making strides in its international growth strategy with a new distribution agreement in...

Continue Reading
Spiral and the National Credit Union Foundation Unite for Members

Updated Category News Views 46

Spiral and the National Credit Union Foundation Unite In an exciting development for credit union members, Spiral, a personalized banking platform, has teamed up with the National Credit Union Foundation to enhance financial literacy and support. As part of this collaboration, the Foundation aims to optimize its outreach to credit union members, providing them with...

Continue Reading